Fluorescence Lifetime Macro Imager for Biomedical Applications
April 7th, 2023
1.5K views
This paper describes the use of a new, fast optical imager for the macroscopic photoluminescence lifetime imaging of long decay emitting samples. The integration, image acquisition, and analysis procedures are described, along with the preparation and characterization of the sensor materials for the imaging and the application of the imager in studying biological samples.
Overview
This study presents a new optical imager designed for macroscopic photoluminescence lifetime imaging, particularly useful in biological samples like live animal tissue. The protocol allows for detailed mapping of phosphorescence lifetime and oxygen concentration, which is crucial for understanding various biological processes.
Key Study Components
Research Area
- Biological imaging
- Phosphorescence lifetime analysis
- Oxygen concentration measurement
Background
- Macroscopic imaging is essential for studying complex biological samples.
- Existing methods may not efficiently analyze long-decaying samples.
- This research aims to enhance visualization techniques in live tissues.
Methods Used
- Optical imaging with time-correlated single-photon counting (TCSPC) mode
- Application on live animal tissues
- Use of custom-designed imaging modules and data processing software
Main Results
- Effective visualization of lifetime and oxygen distribution
- Ability to generate phosphorescence lifetime images with high contrast
- Successful application in observing hypoxic conditions in tissue
Conclusions
- The study demonstrates an innovative imaging approach for biological research.
- Potential applications for diagnosing and treating tissue hypoxia-related conditions.
Frequently Asked Questions
What is the main application of the optical imager?
It is used for the macroscopic imaging of phosphorescence lifetimes and oxygen concentrations in biological tissues.
How does the imaging module operate?
It operates in TCSPC mode for accurate lifetime distribution visualization.
Can this method be used on other models apart from animal tissues?
Currently, it is limited to animal models, but there is potential for broader applications.
What are the key technological components involved?
Key components include a photomultiplier tube, LEDs, and a compact imaging module.
What biological phenomena can this method help study?
It can aid in the study of conditions like cancer, stroke, and inflammation related to tissue hypoxia.
How is data processed after imaging?
Data is processed using custom software to analyze phosphorescence decay and generate images.
What is the significance of phosphorescence lifetime imaging?
It provides insights into the dynamics of oxygen levels in biological tissues, which is crucial for various research fields.
Executive Industry Relevance
Quantitative mapping of tissue oxygenation using phosphorescence lifetime imaging addresses a critical need in preclinical research for accurate hypoxia assessment. This capability enhances predictive confidence in disease modeling and supports mechanistic de-risking for target validation in oncology and metabolic research. The platform's rapid, high-sensitivity imaging enables robust evaluation of tissue microenvironments, informing early-stage portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of tissue oxygenation as a functional biomarker in disease models.
- Supports mechanistic de-risking by providing spatially resolved hypoxia data in live and ex vivo tissues.
- Facilitates target validation by linking oxygen distribution to biological pathway activity.
Screening & Assay Development
- Prepares validated tissue models for downstream compound screening under controlled oxygenation states.
- Delivers reproducible, quantitative lifetime measurements for assay standardization.
- Enables high-throughput readiness by reducing imaging time to under 20 seconds per sample.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant hypoxia signatures for translational continuity.
- Supports metabolic imaging in both ex vivo and live animal systems.
- Provides quantitative endpoints for risk-adjusted advancement of therapeutic candidates.
Pipeline & Workflow Integration
This imaging platform integrates from early discovery through preclinical validation, supporting workflows in target validation, lead identification, and translational research.
- Discovery Biology: Enables hypothesis testing of oxygen-dependent mechanisms in tissue models.
- Screening: Provides standardized, quantitative readouts for assay development and compound evaluation.
- Analytics: Generates spatially resolved, quantitative lifetime and oxygen concentration maps for comparative analysis.
- Translational Research: Bridges discovery and preclinical phases by aligning imaging outputs with disease-relevant hypoxia biomarkers.
- Enterprise Reuse: Offers a modular, reconfigurable imaging capability adaptable to various probes and tissue systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in hypoxia-driven disease models.
- Operational Value: Delivers rapid, reproducible imaging with standardized protocols and flexible probe compatibility.
- Strategic Value: Improves go/no-go decision-making and capital allocation by providing robust quantitative endpoints.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on validated tissue oxygenation data.
Implementation Considerations
- Requires expertise in optical imaging and phosphorescence lifetime analysis.
- Needs access to specialized instrumentation, including TCSPC-capable cameras and image intensifiers.
- Demands cross-team standardization of imaging protocols and data analysis workflows.
- Adaptable to various tissue models and probe chemistries with appropriate configuration.
- Currently limited to animal models; extension to other systems requires further validation.
Biopharma FAQs
Why does null hypothesis testing matter for phosphorescence lifetime mapping?
Null hypothesis testing ensures that observed differences in tissue oxygenation are statistically significant, supporting robust target validation and reducing false positives in hypoxia assessment.
How does independent variable isolation fit the oxygen imaging workflow?
Isolating variables such as probe type, excitation wavelength, and tissue state allows precise attribution of lifetime changes to oxygen concentration, strengthening mechanistic insights in discovery pipelines.
What do quantitative dependent variable measurements enable in tissue imaging?
Quantitative lifetime and oxygen concentration measurements enable direct comparison across samples and conditions, facilitating reproducible assay development and reliable biomarker evaluation.
Why are replication requirements critical for cross-functional imaging studies?
Replication ensures that imaging outputs are consistent and reproducible across teams and experiments, supporting cross-functional collaboration and enterprise-wide data confidence.
What statistical analysis capabilities are required before implementing lifetime imaging?
Robust statistical tools are needed to fit phosphorescence decay curves, validate lifetime distributions, and confirm the reliability of oxygen mapping before integrating imaging data into decision workflows.
